Associated Papers
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
Oh J et al.
Plos One, 2017
Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate.
Bruxel EM et al.
The Pharmacogenomics Journal, 2013
Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans.
Tarkiainen EK et al.
Clinical Pharmacology and Therapeutics, 2012
Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.
Nemoda Z et al.
Neuropharmacology, 2009
Select a paper to view details